Apoptosis in sepsis

Critical Care Medicine

Volumn 28, Issue 4 SUPPL., 2000, Pages

  Mahidhara, Raja ^a   Billiar, Timothy R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Endothelial cell; Hepatocyte; Inducible nitric oxide synthase; Lymphocyte; Neutrophil; Nitric oxide; Sepsis; Systemic Inflammatory response syndrome

Indexed keywords

APOPTOSIS; CELL DEATH; CELL ENERGY; DOWN REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PHENOMENOLOGY; PRIORITY JOURNAL; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0034057558     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200004001-00013     Document Type: Review

References (84)

1. Galley HF, Webster NR: The immunoinflammatory cascade. Br J Anaesth 1996; 77:11-16
2. Bone RC: The pathogenesis of sepsis. Ann Intern Med 1991; 115:457-469
3. Bone RC, Sprung C L, Sibbald WJ: Definitions for sepsis and organ failure. Crit Care Med 1992; 20:724-726
4. Parrillo JE, Parker MM, Natanson C, et al: Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990; 113:227-242
5. Greenman RL, Schein RM, Martin MA, et al: A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of Gram-negative sepsis. The XOMA Sepsis Study Group. JAMA 1991; 266: 1097-1102
6. Ziegler EJ, Fisher CJ Jr, Sprung CL, et al: Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 1991; 324:429-436
7. Abraham E, Wunderink R, Silverman H, et al: Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA 1995; 273:934-941
8. Fisher CJ Jr, Dhainaut JF, Opal SM, et al: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 1994; 271:836-1843
9. Dhainaut JF, Tenaillon A, Le Tulzo Y, et al: Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. Crit Care Med 1994; 22:1720-1728
10. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24, 1125-1128
11. Steller H: Mechanisms and genes of cellular suicide. Science 1995; 267:1445-1449
12. Ekert PG, Vaux DL: Apoptosis and the immune system. Br Med Bull 1997; 53:591-603
13. Cohen JJ, Duke RC, Fadok VA, et al: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992; 10:267-293
14. Kerr JF: Shrinkage necrosis: A distinct mode of cellular death. J Pathol 1971; 105:13-20
15. Kerr JF, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-257
16. Farber E: Programmed cell death: Necrosis versus apoptosis. Mod Pathol 1994; 7:605-609
17. Kane AB: Redefining cell death. Am J Pathol 1995; 146:1-2
18. Wallach D, Varfolomeev EE, Malinin NL, et al: Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999; 17:331-367
19. Cobb JP, Hotchkiss RS, Karl IE, et al: Mechanisms of cell injury and death. Br J Anaesth 1996; 77:3-10
20. Ashkenazi A, Dixit VM: Death receptors: Signaling and modulation. Science 1998; 281: 1305-1308
21. Tibbles LA, Woodgett JR: The stress-activated protein kinase pathways. Cell Mol Life Sci 1999; 55:1230-1254
22. Cohen GM: Caspases: The executioners of apoptosis. Biochem J 1997; 326:1-16
23. Budihardjo I, Oliver H, Lutter M, et al: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999; 15:269-290
24. Ellis HM, Horvitz HR: Genetic control of programmed cell death in the nematode C. elegans. Cell 1986; 44:817-829
25. Yuan J, Shaham S, Ledoux S, et al: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 1993; 75: 641-652
26. Vaux DL, Weissman IL, Kim SK: Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 1992; 258: 1955-1957
27. Hengartner MO, Horvitz HR: C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 1994; 76:665-676
28. Cohen JJ: Apoptosis. Immunol Today 1993; 14:126-130
29. Savill J: Apoptosis in resolution of inflammation. J Leukoc Biol 1997; 61:375-380
30. Majno G, Joris I: Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995; 146:3-15
31. Savill J, Haslett C: Granulocyte clearance by apoptosis in the resolution of inflammation. Semin Cell Biol 1995; 6:385-393
32. Haslett C: Granulocyte apoptosis and inflammatory disease. Br Med Bull 1997; 53: 669-683
33. Sanui H, Yoshida S, Nomoto K, et al: Peritoneal macrophages which phagocytose autologous polymorphonuclear leucocytes in guinea-pigs. I: Induction by irritants and microorgansisms and inhibition by colchicine. Br J Exp Pathol 1982; 63:278-284
34. Savill JS, Wyllie AH, Henson JE, et al: Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989; 83:865-875
35. Grigg JM, Savill JS, Sarraf C, et al: Neutrophil apoptosis and clearance from neonatal lungs. Lancet 1991; 338:720-722
36. Savill J: Macrophage recognition of senescent neutrophils. Clin Sci (Colch) 1992; 83: 649-655
37. Savill J, Smith J, Sarraf C, et al: Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis. Kidney Int. 1992; 42:924-936
38. Whyte MK, Meagher LC, MacDermot J, et al: Impairment of function in aging neutrophils is associated with apoptosis. J Immunol 1993; 150:5124-5134
39. Dransfield I, Buckle AM, Savill JS, et al: Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression. J Immunol 1994; 153:1254-1263
40. 2. J Leukoc Biol 1992; 52:269-273
41. Squier MK, Sehnert AJ, Cohen JJ: Apoptosis in leukocytes. J Leukoc Biol 1995; 57:2-10
42. Watson RW, Redmond HP, Wang JH, et al: Neutrophils undergo apoptosis following ingestion of Escherichia coli. J Immunol 1996; 156:3986-3992
43. Jimenez MF, Watson RW, Parodo J, et al: Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg 1997; 132:1263-1269
44. Fanning NF, Kell M R, Shorten GD, et al: Circulating granulocyte macrophage colony-stimulating factor in plasma of patients with the systemic inflammatory response syndrome delays neutrophil apoptosis through inhibition of spontaneous reactive oxygen species generation. Shock 1999; 11:167-174
45. Ertel W, Keel M, Infanger M, et al: Circulating mediators in serum of injured patients with septic complications inhibit neutrophil apoptosis through up-regulation of protein-tyrosine phosphorylation. J Trauma 1998; 44:767-775
46. Keel M, Ungethum U, Steckholzer U, et al: Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 1997; 90:3356-3363
47. Moulding DA, Walter C, Hart CA, et al: Effects of staphylococcal enterotoxins on human neutrophil functions and apoptosis. Infect Immun 1999; 67:2312-2318
48. Ayala A, Karr SM, Evans TA, et al: Factors responsible for peritoneal granulocyte apoptosis during sepsis. J Surg Res 1997; 69: 67-75
49. Cox G: IL-10 enhances resolution of pulmonary inflammation in vivo by promoting apoptosis of neutrophils. Am J Physiol 1996; 271:L566-L571
50. Russell JH: Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 1995; 7:382-388
51. Surh CD, Sprent J: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994; 372:100-103
52. Van Parijs L, Abbas AK: Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 1998; 280: 243-248
53. Ahmed R, Gray D: Immunological memory and protective immunity: Understanding their relation. Science 1996; 272:54-60
54. Thompson CB, Allison JP: The emerging role of CTLA-4 as an immune attenuator. Immunity 1997; 7:445-450
55. Perez VL, Van Parijs L, Biuckians A, et al: Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement Immunity 1997; 6:411-417
56. Sadlack B, Merz H, Schorle H, et al: Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75: 253-261
57. Suzuki H, Kundig TM, Furlonger C, et al: Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 1995; 268:1472-1476
58. Ayala A, Xu YX, Chung CS, et al: Does Fas ligand or endotoxin contribute to thymic apoptosis during polymicrobial sepsis? Shock 1999; 11:211-217
59. Ayala A, Herdon CD, Lehman DL, et al: Differential induction of apoptosis in lymphoid tissues during sepsis: Variation in onset, frequency, and the nature of the mediators. Blood 1996; 87:4261-4275
60. Ayala A, Xin XY, Ayala CA, et al: Increased mucosal B-lymphocyte apoptosis during polymicrobial sepsis is a Fas ligand but not an endotoxin-mediated process. Blood 1998; 91:1362-1372
61. Chung CS, Xu YX, Wang W, et al: Is Fas ligand or endotoxin responsible for mucosal lymphocyte apoptosis in sepsis? Arch Surg 1998; 133:1213-1220
62. Chung CS, Xu YX, Chaudry IH, et al: Sepsis induces increased apoptosis in lamina propria mononuclear cells which is associated with altered cytokine gene expression. J Surg Res 1998; 77:63-70
63. Hotchkiss RS, Swanson PE, Cobb JP, et al: Apoptosis in lymphoid and parenchymal cells during sepsis: Findings in normal and T-and B-cell-deficient mice. Crit Care Med 1997; 25:1298-1307
64. Hotchkiss RS, Swanson PE, Knudson CM, et al: Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 1999; 162: 4148-4156
65. Haendeler J, Messmer UK, Brune B, et al: Endotoxic shock leads to apoptosis in vivo and reduces Bcl-2. Shock 1996; 6:405-409
66. Bohlinger I, Leist M, Gantner F, et al: DNA fragmentation in mouse organs during endotoxic shock. Am J Pathol 1996; 149: 1381-1393
67. Hiramatsu M, Hotchkiss RS, Karl IE, et al: Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway. Shock 1997; 7:247-253
68. Hotchkiss RS, Swanson PE, Freeman BD, et al: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27:1230-1251
69. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, et al: Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 1997; 186:1831-1841
70. Drab-Weiss EA, Hansra IK, Blazek ER, et al: Aminothiols protect endothelial cell proliferation against inhibition by lipopolysaccharide. Shock 1998; 10:423-429
71. DeMeester SL, Qiu Y, Buchman TG, et al: Nitric oxide inhibits stress-induced endothelial cell apoptosis. Crit Care Med 1998; 26: 1500-1509
72. DeMeester SL, Buchman TG, Qiu Y, et al: Heat shock induces IkappaB-alpha and prevents stress-induced endothelial cell apoptosis. Arch Surg 1997; 132:1283-1287
73. Hu X, Yee E, Harlan JM, et al: Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. Blood 1998; 92:2759-2765
74. Tzeng E, Kim YM, Pitt BR, et al: Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. Surgery 1997; 122:255-263
75. Ceneviva GD, Tzeng E, Hoyt DG, et al: Nitric oxide inhibits lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells. Am J Physiol 1998; 275:L717-L728
76. Dimmeler S, Haendeler J, Nehls M, et al: Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 1997; 185:601-607
77. Ou J, Carlos TM, Watkins SC, et al: Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia. Nitric Oxide 1997; 1:404-416
78. Kim YM, Talanian RV, Billiar TR: Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997; 272: 31138-31148
79. Kim YM, Kim TH, Seol DW, et al: Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. J Biol Chem 1998; 273:31437-31441
80. Li J, Bombeck CA, Yang S, et al: Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes. J Biol Chem 1999; 274:17325-17333
81. Mannick JB, Miao XQ, Stamler JS: Nitric oxide inhibits Fas-induced apoptosis. J Biol Chem 1997; 272:24125-24128
82. Ford H, Watkins S, Reblock K, et al: The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 1997; 32:275-282
83. Klosterhalfen B, Hauptmann S, Offner FA, et al: Induction of heat shock protein 70 by zinc-bis-(DL-hydrogenaspartate) reduces cytokine liberation, apoptosis, and mortality rate in a rat model of LD100 endotoxemia. Shock 1997; 7:254-262
84. Cobb JP, Hotchkiss RS, Swanson PE, et al: Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice. Surgery 1999; 126:438-442